Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Chelyabinsk Metallurgical Plant reported for 9 months of 2024 by RAS

11/2/24 CHKZ

Sistema reported for 9 months of 2024 by RAS

11/2/24 AFKS

Lenta opened the first darkstore in St. Petersburg

11/1/24 LENT

El5-Energo reported for 9 months of 2024 under RAS

11/1/24 ELFV

Artgen reported for 9 months of 2024 by RAS

11/1/24 ABIO

Board of Directors of Sebcement recommended dividends

11/1/24 SKCM

LLC KVLZ Kristall reported for 9 months of 2024

11/1/24 KLVZ

Arsagera reported for 9 months of 2024 by RAS

11/1/24 ARSA

YTEK reported for 9 months of 2024 by RAS

11/1/24 YAKG

Novatek reports for 9 months of 2024 by RAS

11/1/24 NVTK